Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | LTA4H | P09960 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28929100 | 0.86 | FDPS (0.43) | FDPSHDAC1HDAC6LTA4HHPGD | |
| SCHEMBL30586378 | 0.83 | HPGD (0.39) | FDPSHDAC1HDAC6LTA4HHPGD | |
| SCHEMBL4558644 | 0.83 | FDPS (0.54) | FDPSHDAC1HDAC6LTA4HALDH1A1 | |
| SCHEMBL28817988 | 0.80 | FDPS (0.54) | FDPSHDAC1HDAC6LTA4HALDH1A1 | |
| SCHEMBL10857669 | 0.80 | FDPS (0.54) | FDPSHDAC1HDAC6LTA4HALDH1A1 | |
| SCHEMBL4592188 | 0.80 | FDPS (0.51) | FDPSHDAC1HDAC6LTA4HALDH1A1 | |
| SCHEMBL28615898 | 0.79 | AHCY (0.55) | FDPSHDAC1HDAC6LTA4HALDH1A1 | |
| SCHEMBL27932506 | 0.79 | FDPS (0.53) | FDPSHDAC1HDAC6LTA4HALDH1A1 | |
| SCHEMBL434034 | 0.78 | FDPS (0.44) | FDPSHDAC1HDAC6LTA4HALDH1A1 | |
| SCHEMBL3671306 | 0.77 | FDPS (0.51) | FDPSHDAC1HDAC6LTA4HADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3377104-B1 | MODULATING PERMEABILITY OF THE BLOOD CEREBROSPINAL FLUID BARRIER | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2022-12-21 | — | — | EP | claimed |
| CN-108472370-B | Modulating blood cerebrospinal fluid barrier permeability | 纪念斯隆-凯特琳癌症中心 | 2022-07-12 | — | — | CN | claimed |
| CN-100490818-C | Methods for treating hepatitis delta virus infection with beta-L-2' deoxy-uncleosides | NOVARTIS AG (CH) | 2009-05-27 | — | — | CN | claimed |
| CN-101099745-A | Methods and compositions for treating flaviviruses and pestiviruses | IDENIX CAYMAN LTD (VG) | 2008-01-09 | — | — | CN | claimed |
| CN-1849142-A | 2'-branched nucleosides and flaviviridae mutation | IDENIX CAYMAN LTD (KY) | 2006-10-18 | — | — | CN | claimed |
| CN-114990591-B | Method for synthesizing chiral acyclic nucleoside compound by electrochemical asymmetric dihydroxylation reaction | 河南师范大学 | 2024-02-20 | — | — | CN | disclosed |
| CN-116693394-A | Dehydrazine method and application | 大连理工大学 | 2023-09-05 | — | — | CN | disclosed |
| WO-2023028605-A1 | COMPOSITIONS FOR TARGETING FLI-1 AND METHODS OF USE THEREOF | MUSC FOUNDATION FOR RESEARCH DEVELOPMENT D/B/A ZUCKER INSTITUTE FOR INNOVATION COMMERCIALIZATION (US) | 2023-03-02 | — | — | WO | disclosed |
| EP-3377104-B1 | MODULATING PERMEABILITY OF THE BLOOD CEREBROSPINAL FLUID BARRIER | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2022-12-21 | — | — | EP | disclosed |
| CN-115282277-A | Modulating blood cerebrospinal fluid barrier permeability | 纪念斯隆-凯特琳癌症中心 | 2022-11-04 | — | — | CN | disclosed |
| CN-114990591-A | Method for synthesizing chiral acyclic nucleoside compound by electrochemical asymmetric dihydroxylation reaction | 河南师范大学 | 2022-09-02 | — | — | CN | disclosed |
| CN-108472370-B | Modulating blood cerebrospinal fluid barrier permeability | 纪念斯隆-凯特琳癌症中心 | 2022-07-12 | — | — | CN | disclosed |
| WO-2004050839-A2 | FRAGMENTATION-BASED METHODS AND SYSTEMS FOR SEQUENCE VARIATION DETECTION AND DISCOVERY | SEQUENOM, INC. (US) | 2004-06-17 | — | — | WO | disclosed |
| CN-1473201-A | Method for amplification and optional characterisation of nucleic acids | �������ƿ˹�����ѧ�ƿ�ѧԺ | 2004-02-04 | — | — | CN | disclosed |
| CN-1444483-A | Methods of treating hepatitis delta virus infection with beta-L-2' -deoxynucleosides | EDENNICKS CAYMAN CO LTD (KY) | 2003-09-24 | — | — | CN | disclosed |
| CN-1402729-A | Polycycloalkylpurines as adenosine receptor antagonists | BIOGEN INC (US) | 2003-03-12 | — | — | CN | disclosed |
| EP-0475411-B1 | Novel carbocyclic adenosine analogs useful as immunosuppressants | AVENTIS PHARMA INC (US) | 2001-06-13 | — | — | EP | disclosed |
| WO-2000006573-A1 | ANTIVIRAL ALKYL SUBSTITUTED PURINE DERIVATIVES AND THEIR PREPARATION | Kemijski inštitut (SI) | 2000-02-10 | — | — | WO | disclosed |
| EP-0664294-A1 | Production of nucleoside analogues | Reese, Colin (GB) | 1995-07-26 | — | — | EP | disclosed |
| EP-0264081-A3 | OXADIAZOLYL ALKYL PURIN DERIVATIVES, THEIR PREPARATION AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS | — | 1989-11-15 | — | — | EP | disclosed |